Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 49.92
+0.40 (0.81%)
Aug 21, 2026, 3:59 PM HKT
HKG:6609 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,890 | 2,051 | 837 | 1,135 | 1,417 | 4,070 | |
Market Cap Growth | -12.68% | 145.03% | -26.22% | -19.93% | -65.18% | - |
Enterprise Value | 1,062 | 1,315 | 99 | 378 | 299 | 3,477 |
Last Close Price | 49.92 | 53.70 | 21.95 | 29.75 | 36.75 | 104.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.39 | 22.12 | - | - | - | - |
Forward PE | - | 33.00 | 29.68 | - | - | - |
PS Ratio | 4.16 | 4.51 | 2.83 | 4.43 | 6.85 | 36.80 |
PB Ratio | 1.50 | 1.63 | 0.74 | 0.96 | 1.08 | 2.42 |
P/TBV Ratio | 1.56 | 1.69 | 0.77 | 1.00 | 1.12 | 2.51 |
P/FCF Ratio | 11.91 | 12.93 | - | - | - | - |
P/OCF Ratio | 11.02 | 11.96 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.34 | 2.89 | 0.33 | 1.48 | 1.45 | 31.45 |
EV/EBITDA Ratio | 13.42 | 18.34 | - | - | - | - |
EV/EBIT Ratio | 21.56 | 26.69 | - | - | - | - |
EV/FCF Ratio | 6.70 | 8.29 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 |
Debt / EBITDA Ratio | 0.60 | 0.60 | - | - | - | - |
Debt / FCF Ratio | 0.30 | 0.30 | - | - | - | - |
Net Debt / Equity Ratio | -0.66 | -0.66 | -0.64 | -0.64 | -0.70 | -0.86 |
Net Debt / EBITDA Ratio | -11.54 | -11.54 | 68.68 | 6.68 | 4.72 | 7.73 |
Net Debt / FCF Ratio | -5.22 | -5.22 | 93.21 | 7.36 | 2.70 | 4.55 |
Asset Turnover | 0.33 | 0.33 | 0.23 | 0.19 | 0.13 | 0.08 |
Inventory Turnover | 0.81 | 0.81 | 0.66 | 0.58 | 0.72 | 1.72 |
Quick Ratio | 9.33 | 9.33 | 9.85 | 13.50 | 13.40 | 22.43 |
Current Ratio | 11.49 | 11.49 | 12.42 | 16.82 | 16.77 | 24.05 |
Return on Equity (ROE) | 7.60% | 7.60% | -1.27% | -8.39% | -15.79% | -19.18% |
Return on Assets (ROA) | 2.21% | 2.21% | -1.73% | -6.31% | -8.86% | -8.76% |
Return on Invested Capital (ROIC) | 10.99% | 11.05% | -8.60% | -34.43% | -73.55% | -113.95% |
Return on Capital Employed (ROCE) | 3.70% | 3.70% | -3.00% | -11.10% | -16.00% | -11.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.91% | 4.52% | -1.73% | -9.13% | -15.99% | -5.86% |
FCF Yield | 8.39% | 7.73% | -0.92% | -9.03% | -24.20% | -7.80% |
Buyback Yield / Dilution | -0.47% | -0.47% | 0.81% | 0.51% | -14.60% | -52.84% |